Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 03 06 2020
revised: 21 06 2020
accepted: 23 06 2020
pubmed: 1 7 2020
medline: 20 9 2020
entrez: 30 6 2020
Statut: ppublish

Résumé

Rapid detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for the diagnosis of coronavirus disease 2019 (COVID-19) and preventing the spread of the virus. A novel detection kit - the 2019 Novel Coronavirus Detection Kit (nCoV-DK) - halves the detection time by eliminating the steps of RNA extraction and purification. We evaluated the concordance between the nCoV-DK and direct PCR. The virus was detected in 53/71 specimens (74.6%) by direct PCR and in 55/71 specimens (77.5%) by nCoV-DK; the overall concordance rate was 94.4%: 95.2% for nasopharyngeal swab, 95.5% for saliva, and 85.7% for sputum. The nCoV-DK test effectively detects SARS-CoV-2 in all types of sample including saliva, while reducing the time required for detection, labor, and the risk of human error.

Identifiants

pubmed: 32599282
pii: S1201-9712(20)30509-9
doi: 10.1016/j.ijid.2020.06.074
pmc: PMC7318955
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-17

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

J Infect. 2020 Aug;81(2):e145-e147
pubmed: 32504740
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32317257
Clin Chem. 2013 Jul;59(7):1118-22
pubmed: 23564756
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
J Infect. 2020 Jul;81(1):e45-e50
pubmed: 32298676
J Virol Methods. 2010 Feb;163(2):282-6
pubmed: 19878699
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775

Auteurs

Tatsuya Fukumoto (T)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Sumio Iwasaki (S)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Shinichi Fujisawa (S)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Kasumi Hayasaka (K)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Kaori Sato (K)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Satoshi Oguri (S)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Keisuke Taki (K)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Sho Nakakubo (S)

Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Keisuke Kamada (K)

Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Yu Yamashita (Y)

Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Satoshi Konno (S)

Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Mutsumi Nishida (M)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Junichi Sugita (J)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.

Takanori Teshima (T)

Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan. Electronic address: teshima@med.hokudai.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH